Some antihyperglycemic agents used to treat T2D, such as insulin, sulfonylureas and thiazolidinediones, can lead to weight gain and frequent episodes of hypoglycemia, which are associated with reduced quality of life and increased cardiovascular events
NHS Access and Eligibility NHS access for both medications is currently limited, but things are changing: Weight management (Specialist services): Both Mounjaro and Wegovy are available through NHS specialist weight management services
For Men and Women PT-141 is one of the few sexual enhancement treatments effective for both genders
Resistance training is particularly important during significant weight loss to help preserve lean muscle mass
Eligible new patients can receive 14 free tablets of the 7 mg starter dose a two-week supply to begin their treatment journey
This means your resting metabolic rate may gradually decline while on the medication, making post-discontinuation caloric balance harder without conscious dietary adjustment